VEGF165b augments NK92 cytolytic activity against human K562 leukemia cells by upregulating the levels of perforin and granzyme B via the VEGR1-PLC pathway

Publication date: December 2020Source: Molecular Immunology, Volume 128Author(s): Xiaoyin Wang, Chen Liang, Wenjiao Xia, Changjiang Guo, Zhiyuan Niu, Wuling Zhu, Huiyong Zhang
Source: Molecular Immunology - Category: Allergy & Immunology Source Type: research